evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system

Written bySapio Sciences
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

Zurich-based evitria has established itself as a premier CHO-based transient expression services provider for antibodies and other recombinant proteins, serving a diverse clientele ranging from academic laboratories to global biopharmaceutical companies.

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system.

<b ><span lang="EN-US">Stefan Schmidt, CEO of evitria</span></b>

Stefan Schmidt, CEO of evitria, commented: “Working with Sapio Sciences marks a significant step forward in our workflow and data management capabilities. The highly flexible Sapio solution nicely captures our existing workflows, streamlining data capture and processing, requiring only limited retooling of our processes or retraining for our employees. It also provides a platform for future growth and optimization, and we are confident that this integration will enhance our ability to serve our global client base with even greater efficiency and precision.”




<b ><span lang="EN-US">Mike McCartney, Chief Commercial Officer at Sapio</span></b>

Mike McCartney, Chief Commercial Officer at Sapio, commented: “We are thrilled to partner with evitria, a true innovator in antibody expression services. The Sapio platform was designed to meet the evolving needs of life sciences organizations like evitria, reinforcing our mission to elevate science and empower scientists. Our team’s deep understanding of scientific workflows allowed us to address evitria’s specific needs and showcase our commitment to accelerating discovery and improving lives.”





Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo
Golden geometric pattern on a blue background, symbolizing the precision, consistency, and technique essential to effective pipetting.

Best Practices for Precise Pipetting

Integra Logo
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel